TerminatedPhase 2

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

Stopped: Slow recruitment compounded by COVID-19

United States44 participantsStarted 2019-04-26

Plain-language summary

The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D\&E) procedures.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Chronic adrenal failure or insufficiency
✕. Concurrent use of long-term corticosteroid therapy
✕. Inherited porphyrias

What they're measuring

Number of Participants That Had Placement of Expected Dilators or More

Timeframe: At time of 1 hour clinic visit (10 minutes)

Trial details

NCT IDNCT03714880

SponsorUniversity of California, Davis

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-02-26

Results submitted2022-03-30

View on ClinicalTrials.gov More Second Trimester Abortion trials